TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15259289

Group type: EXPERIMENTAL
Intervention: 1 mg 17beta-estradiol combined with 1, 2 or 3 mg drospirenone daily
Number of subjects: 180

Group type: COMPARATOR
Intervention: 1 mg drospirenone
Number of subjects: 180
Study: 10790458

Group type: EXPERIMENTAL
Intervention: Asthma education and medical treatment in the setting of a tertiary care pediatric allergy clinic with monthly contact from an asthma outreach nurse.
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard care (control group).
Number of subjects: 80
Study: 9071565

Group type: EXPERIMENTAL
Intervention: Pro-inflammatory cytokines (IL-6, IL-8, TNF-alpha)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Anti-inflammatory cytokines (IL-10, TNFsrI, TNFsrII)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Serum nitrate levels
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Serum nitrate levels in patients with positive blood cultures (n = 4)
Number of subjects: 23
Study: 8379858

Group type: EXPERIMENTAL
Intervention: Estradiol gel (1.25 g)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Estradiol gel (2.5 g)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 61
Study: 3093704

Group type: EXPERIMENTAL
Intervention: Specific refeeding protocols with enteral formulas
Number of subjects: 16
Study: 30973606

Group type: EXPERIMENTAL
Intervention: Low-fat dietary pattern
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 29354970

Group type: EXPERIMENTAL
Intervention: Acupuncture at the twelve jing-well points (20 treatments, once a day) combined with bladder function training
Number of subjects: 63

Group type: COMPARATOR
Intervention: Routine clinical medication and bladder function training
Number of subjects: 63
Study: 26463866

Group type: EXPERIMENTAL
Intervention: Hybrid Surgery (HS)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cervical Disc Arthroplasty (CDA)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Anterior Cervical Discectomy and Fusion (ACDF)
Number of subjects: 20
Study: 23305118

Group type: EXPERIMENTAL
Intervention: Acute resistance training session (RT) - three sets at 60% of one-repetition maximum (1RM) with 1 minute rest between exercises and sets
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control session (CON) - seated for 30 minutes
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Acute resistance training session (RT)
Number of subjects: 27
Study: 21698665

Group type: EXPERIMENTAL
Intervention: 100 µg of 17β-estradiol (with cyclic progesterone) transdermally for 18 months
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Incremental low-dose oral ethinyl-estradiol (3.75 µg daily from 0 to 6 months, 7.5 µg from 6 to 12 months, 11.25 µg from 12 to 18 months)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study: 18054621

Group type: EXPERIMENTAL
Intervention: ePTFE dural substitute
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard reconstruction
Number of subjects: 60
Study: 16563207

Group type: EXPERIMENTAL
Intervention: Illness perceptions about psychosis
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Self-reported medication adherence
Number of subjects: 100
Study: 14559846

Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 185

Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 185
Study: 11030881

Group type: EXPERIMENTAL
Intervention: Novel collagen-based composite combined with autologous plasma
Number of subjects: 67

Group type: COMPARATOR
Intervention: Collagen sponge applied with pressure (Control)
Number of subjects: 67
Study: 8833315

Group type: EXPERIMENTAL
Intervention: EEG biofeedback training (40 sessions of 45 minutes each over 6 months)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: EEG biofeedback training
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (waiting list, no EEG biofeedback)
Number of subjects: 18
Study: 1385295

Group type: EXPERIMENTAL
Intervention: Acyclovir (400 mg twice daily)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Isoprinosine (500 mg twice daily)
Number of subjects: 127
Study: 2856766

Group type: EXPERIMENTAL
Intervention: Oxprenolol
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Nitrendipine
Number of subjects: 30
Study: 28419217

Group type: EXPERIMENTAL
Intervention: Dual coil (DC) electrodes
Number of subjects: 1077

Group type: COMPARATOR
Intervention: Single coil (SC) electrodes
Number of subjects: 1077
Study: 28330680

Group type: EXPERIMENTAL
Intervention: Screening questionnaire assessing depressive symptoms (PHQ‐9) and anxiety symptoms (GAD‐7)
Number of subjects: 1837

Group type: EXPERIMENTAL
Intervention: Participation in the trial
Number of subjects: 1837

Group type: EXPERIMENTAL
Intervention: Factors related to participation
Number of subjects: 1837

Group type: COMPARATOR
Intervention: Non-responders characteristics
Number of subjects: 1837
Study: 26155839

Group type: EXPERIMENTAL
Intervention: Interprofessional simulation-based education
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional course
Number of subjects: 0
Study: 23527365

Group type: EXPERIMENTAL
Intervention: Double-flap incision (DFI)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Conventional periosteal releasing incision (PRI)
Number of subjects: 23
Study: 21034369

Group type: EXPERIMENTAL
Intervention: Pupil light reflex (PLR) evaluation using pupillometry with single flash stimuli of 24.6 candelas/m(2) intensity and 20 ms duration
Number of subjects: 110

Group type: COMPARATOR
Intervention: Pupil light reflex (PLR) evaluation using pupillometry
Number of subjects: 110
Study: 18444146

Group type: EXPERIMENTAL
Intervention: 400-mcg/day of Se
Number of subjects: 424

Group type: COMPARATOR
Intervention: 200-mcg/day of Se
Number of subjects: 424
Study: 16490580

Group type: EXPERIMENTAL
Intervention: Sitagliptin 25, 50, 100, 200, or 400 mg QD for 10 days
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Sitagliptin 800 mg on day 1 followed by 600 mg QD on days 3 to 10
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Sitagliptin 300 mg BID for 10 days
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 15085170

Group type: EXPERIMENTAL
Intervention: Regular meal pattern (6 meals/day)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Irregular meal pattern (variable meals between 3 and 9 meals/day)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Irregular meal pattern
Number of subjects: 9

Group type: COMPARATOR
Intervention: Regular meal pattern
Number of subjects: 9
Study: 11368283

Group type: EXPERIMENTAL
Intervention: Topical corticosteroids (e.g., betamethasone sodium phosphate, beclomethasone dipropionate, fluticasone propionate, budesonide)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topical corticosteroids (e.g., beclomethasone dipropionate, flunisolide, budesonide)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9397300

Group type: EXPERIMENTAL
Intervention: Smokers
Number of subjects: 2121

Group type: EXPERIMENTAL
Intervention: Ex-smokers
Number of subjects: 2121

Group type: EXPERIMENTAL
Intervention: Never smokers
Number of subjects: 2121

Group type: COMPARATOR
Intervention: Smokers vs Ex-smokers and Never smokers
Number of subjects: 2121

Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 2121
Study: 7932953

Group type: EXPERIMENTAL
Intervention: Bilateral lower extremity CUS examinations
Number of subjects: 86

Group type: COMPARATOR
Intervention: Unilateral lower limb sonographic studies
Number of subjects: 86
Study: 2458659

Group type: EXPERIMENTAL
Intervention: Epidural analgesia
Number of subjects: 16

Group type: COMPARATOR
Intervention: Epidural analgesia + assumed blockade of prostaglandin synthesis, blockade of receptors for histamine1, histamine2 and serotonin2, and inhibition of fibrinolysis with indomethacin, astemizole, ranitidine, ketanserin and tranexamic acid
Number of subjects: 16
Study: 29289580

Group type: EXPERIMENTAL
Intervention: Gym-based exercise program and health coaching for 12 months
Number of subjects: 105

Group type: COMPARATOR
Intervention: Home-based exercise program and health coaching for 12 months with telephone follow-up for the first 10 weeks
Number of subjects: 105
Study: 27852382

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided lower extremity nerve block (group N)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Spinal anesthesia (group S)
Number of subjects: 80
Study: 25496342

Group type: EXPERIMENTAL
Intervention: Tai Chi combined with conventional rehabilitation therapies
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard conventional rehabilitation therapies
Number of subjects: 50
Study: 22825094

Group type: EXPERIMENTAL
Intervention: Self-administered misoprostol (400 μg vaginally or buccally 3-4 hours before IUD insertion)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo (vaginally or buccally 3-4 hours before IUD insertion)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Self-administered misoprostol
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study: 20560169

Group type: EXPERIMENTAL
Intervention: Intensive physical activity (home-based exercise on a bicycle ergometer)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Usual sedentary life (control group)
Number of subjects: 62
Study: 18996858

Group type: EXPERIMENTAL
Intervention: Cyclosporine (2.5 mg x kg(‐1)d(‐1)) plus low-calorie diet
Number of subjects: 61

Group type: COMPARATOR
Intervention: Cyclosporine alone
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 61
Study: 16186076

Group type: EXPERIMENTAL
Intervention: black cohosh 160 mg daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: multibotanical (50 mg black cohosh, alfalfa, chaste tree, dong quai, false unicorn, licorice, oats, pomegranate, Siberian ginseng, boron) four capsules daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: multibotanical plus telephone counseling to increase dietary soy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: conjugated equine estrogen 0.625 mg +/- 2.5 mg medroxyprogesterone acetate
Number of subjects: 0

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study: 12517545

Group type: EXPERIMENTAL
Intervention: Morphine sulphate (MS)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 74
Study: 10767897

Group type: EXPERIMENTAL
Intervention: Records with less-than-usual intake
Number of subjects: 1090

Group type: EXPERIMENTAL
Intervention: Records with more-than-usual intake
Number of subjects: 1090

Group type: COMPARATOR
Intervention: Typical intake days
Number of subjects: 1090
Study: 8814966

Group type: EXPERIMENTAL
Intervention: Red wine
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: White wine
Number of subjects: 24

Group type: COMPARATOR
Intervention: Grape juice (high phenols)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Grape juice (low phenols)
Number of subjects: 24
Study: 1325853

Group type: EXPERIMENTAL
Intervention: AVP antagonist (10 micrograms/kg body weight i.v.)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Nicotine infusion (1.0 micrograms/kg body weight per min)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: AVP antagonist (5 micrograms/kg i.v.)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Nicotine infusion plus AVP antagonist i.v.
Number of subjects: 21
Study: 6238558

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (IB) 40 micrograms four times a day
Number of subjects: 28

Group type: COMPARATOR
Intervention: Metaproterenol (MP) 1.5 mg four times a day
Number of subjects: 28
Study: 31584181

Group type: EXPERIMENTAL
Intervention: Cone beam computed tomography (CBCT) analysis of bony nasolacrimal canal
Number of subjects: 100

Group type: COMPARATOR
Intervention: Gender comparison (female vs male)
Number of subjects: 100
Study: 29804882

Group type: EXPERIMENTAL
Intervention: midazolam–alfaxalone
Number of subjects: 7

Group type: COMPARATOR
Intervention: midazolam–ketamine
Number of subjects: 7
Study: 27007793

Group type: EXPERIMENTAL
Intervention: Low-dose spironolactone (25 mg daily)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Alternative antihypertensive regimen
Number of subjects: 17
Study: 24758530

Group type: EXPERIMENTAL
Intervention: 6 weeks of short one-to-one telephone calls followed by 12 weeks of group telephone calls led by a trained volunteer facilitator
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 70
Study: 21830007

Group type: EXPERIMENTAL
Intervention: Physiotherapy program
Number of subjects: 50

Group type: COMPARATOR
Intervention: Routine nursing care
Number of subjects: 50
Study: 20154294

Group type: EXPERIMENTAL
Intervention: Developmental formulations of paracetamol (acetaminophen)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Commercial products of paracetamol (acetaminophen)
Number of subjects: 25

Group type: COMPARATOR
Intervention: All formulations (developmental and commercial)
Number of subjects: 25
Study: 18316826

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 1815
Study: 16491770

Group type: EXPERIMENTAL
Intervention: Minimally invasive surgery (group I)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Bilateral neck surgery (group II)
Number of subjects: 15
Study: 12841808

Group type: EXPERIMENTAL
Intervention: Text + pictogram information (experimental group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Text-only information (control group)
Number of subjects: 60
Study: 10472325

Group type: EXPERIMENTAL
Intervention: Acyclovir (ACV) 15 mg/kg i.v. over one hour every 8 hours for 42 doses
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Valacyclovir (VCV) 2 g every 8 hours for a total of 42 doses (after switching from ACV)
Number of subjects: 10
Study: 8707374

Group type: EXPERIMENTAL
Intervention: ELISA test
Number of subjects: 66

Group type: COMPARATOR
Intervention: Standard agglutination test
Number of subjects: 66
Study: 1681158

Group type: EXPERIMENTAL
Intervention: Microscopy examination of fresh unspun and unstained urine specimens
Number of subjects: 342

Group type: COMPARATOR
Intervention: Culture of initial urine specimens
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: Microscopy examination of subsequent urine specimens
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: Microscopy as a screening test
Number of subjects: 342
Study: 3908330

Group type: EXPERIMENTAL
Intervention: Aluminum ibuprofen suspension (200 mg)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Acetaminophen with codeine elixir (240 mg and 24 mg)
Number of subjects: 154

Group type: COMPARATOR
Intervention: All four groups (including placebo)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Placebo liquid
Number of subjects: 154
Study: 30488273

Group type: EXPERIMENTAL
Intervention: SpineJack® (SJ)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Balloon Kyphoplasty (BKP)
Number of subjects: 30
Study: 29925893

Group type: EXPERIMENTAL
Intervention: Stepped and collaborative care model (SCM)
Number of subjects: 737

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 737
Study: 26679630

Group type: EXPERIMENTAL
Intervention: Fish oil supplementation (5 capsules daily providing 2.0 g/d EPA and 1.0 g/d DHA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fish oil supplementation
Number of subjects: 0
Study: 24886098

Group type: EXPERIMENTAL
Intervention: Extended multi-method simulation (two week-long simulations)
Number of subjects: 84
Study: 22381341

Group type: EXPERIMENTAL
Intervention: 3 weeks Kirschner wire transfixion
Number of subjects: 52

Group type: COMPARATOR
Intervention: 6 weeks Kirschner wire transfixion
Number of subjects: 52
Study: 20022996

Group type: EXPERIMENTAL
Intervention: Body-weight-supported treadmill training (BWSTT)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Lower-extremity resistive cycling
Number of subjects: 15

Group type: COMPARATOR
Intervention: Lower-extremity progressive, resistive strengthening
Number of subjects: 15

Group type: COMPARATOR
Intervention: Sham condition of arm ergometry
Number of subjects: 15
Study: 21093877

Group type: EXPERIMENTAL
Intervention: PleuraSeal (sealant group)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Control (standard lung closure only)
Number of subjects: 121
Study: 15755229

Group type: EXPERIMENTAL
Intervention: Smoking cessation treatment
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Diet treatment
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Physical activity treatment
Number of subjects: 76
Study: 12460128

Group type: EXPERIMENTAL
Intervention: Cannabis abuse treatment
Number of subjects: 600
Study: 15512100

Group type: EXPERIMENTAL
Intervention: Artemether
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Artemether and mefloquine
Number of subjects: 45
Study: 8081560

Group type: EXPERIMENTAL
Intervention: Ondansetron
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Droperidol
Number of subjects: 0
Study: 2916767

Group type: EXPERIMENTAL
Intervention: Smoking (two standard cigarettes)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham smoking (unlit cigarette)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham smoking
Number of subjects: 12
Study: 29804294

Group type: EXPERIMENTAL
Intervention: 10-day high-dose proton pump inhibitor triple therapy (HD-PPI-TT) with 60 mg lansoprazole, 500 mg clarithromycin, and 1 g amoxicillin, each administered twice daily for 10 days
Number of subjects: 120

Group type: COMPARATOR
Intervention: 10-day sequential therapy (ST) with 30 mg lansoprazole and 1 g amoxicillin for 5 days followed by 30 mg lansoprazole, 500 mg clarithromycin, and 400 mg metronidazole for 5 days
Number of subjects: 120

Group type: COMPARATOR
Intervention: 10-day sequential therapy (ST)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 10-day high-dose proton pump inhibitor triple therapy (HD-PPI-TT)
Number of subjects: 120
Study: 28446253

Group type: EXPERIMENTAL
Intervention: Multifaceted intervention including motivational interviewing (MI) and psychoeducation
Number of subjects: 270

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 270
Study: 23241449

Group type: EXPERIMENTAL
Intervention: Early invitation to food supplementation (608 kcal 6 days per week)
Number of subjects: 4436

Group type: EXPERIMENTAL
Intervention: Multiple micronutrient supplementation (MMS) (15 micronutrients)
Number of subjects: 4436

Group type: COMPARATOR
Intervention: Usual invitation to food supplementation (around 20 weeks)
Number of subjects: 4436

Group type: EXPERIMENTAL
Intervention: Double-masked supplementation with either 30 mg Fe and 400 μg folic acid or 60 mg Fe and 400 μg folic acid
Number of subjects: 4436
Study: 23888001

Group type: EXPERIMENTAL
Intervention: Prior treatment with antipsychotic long-acting injection (LAI)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Clozapine (as a randomised treatment)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Non-clozapine oral SGA (as a randomised treatment)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Switch from LAI to oral antipsychotic
Number of subjects: 155
Study: 21964170

Group type: EXPERIMENTAL
Intervention: Genomic risk information from a DTC product plus usual care
Number of subjects: 150

Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 150
Study: 17996208

Group type: EXPERIMENTAL
Intervention: PHMB 0.02%
Number of subjects: 55

Group type: COMPARATOR
Intervention: Chlorhexidine 0.02%
Number of subjects: 55
Study: 16729916

Group type: EXPERIMENTAL
Intervention: Cilengitide at 2000 mg in patients with nonmetastatic androgen-independent prostate cancer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cilengitide at 500 mg or 2000 mg, intravenously twice weekly in patients with metastatic prostate cancer
Number of subjects: 0
Study: 12588933

Group type: EXPERIMENTAL
Intervention: 4 mg reboxetine
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 8 mg reboxetine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 10986311

Group type: EXPERIMENTAL
Intervention: DMARDs and/or corticosteroids
Number of subjects: 90
Study: 8776365

Group type: EXPERIMENTAL
Intervention: Terbinafine for 1 week
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Terbinafine for 2 weeks
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Terbinafine for 4 weeks
Number of subjects: 161
Study: 1594740

Group type: EXPERIMENTAL
Intervention: Education program focused on health care professionals' use of basic communication skills, including a self-study instructional text and a 20-minute companion video.
Number of subjects: 0
Study: 3972526

Group type: EXPERIMENTAL
Intervention: Iohexol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Metrizamide
Number of subjects: 40
Study: 30388597

Group type: EXPERIMENTAL
Intervention: Laparoscopic sleeve gastrectomy (LSG)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Obese controls (Ctr)
Number of subjects: 22
Study: 29734817

Group type: EXPERIMENTAL
Intervention: Thin cement mantle group (n = 16)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Thick cement mantle group (n = 14)
Number of subjects: 30
Study: 26847421

Group type: EXPERIMENTAL
Intervention: Breast Density (BD) information
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Imaging technology information
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: BD information and imaging technology information (combined)
Number of subjects: 138
Study: 25370394

Group type: EXPERIMENTAL
Intervention: Topical Anesthesia (TA)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Peribulbar Anesthesia (PA)
Number of subjects: 1000
Study: 23165810

Group type: EXPERIMENTAL
Intervention: Ephedrine
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Lidocaine
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 140

Group type: COMPARATOR
Intervention: NaCl solution (Placebo)
Number of subjects: 140
Study: 20388445

Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 61

Group type: COMPARATOR
Intervention: Wait-list group (Control)
Number of subjects: 61
Study: 18598095

Group type: EXPERIMENTAL
Intervention: Acetyl-L-carnitine (ALC) 1180 mg/day
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Thioctic acid 600 mg/day
Number of subjects: 64
Study: 15842525

Group type: EXPERIMENTAL
Intervention: Metformin 1 g orally
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8